Both in Biotechnology
Biogen vs Moderna
Over the past year BIIB returned +67.5% and MRNA returned +790.1%; their daily moves had a correlation of 0.22.
BIIB +67.5% MRNA +790.1%Growth of $1, one year, split-adjusted
| Metric | BIIB | MRNA |
|---|---|---|
| Price | $253.62 | $221.72 |
| Market cap | $37.49B | $88.52B |
| Today | +1.59% | −0.47% |
| 1 month | +13.8% | +17.3% |
| 6 months | +35.6% | +388.7% |
| Year to date | +44.1% | +651.8% |
| 1 year | +71.5% | +797.7% |
| Revenue growth (YoY) | +10.6% | +2.1% |
| Gross margin | 73.3% | 35.9% |
| Net margin | −0.7% | −539.3% |
| P/E (TTM) | 107.9× | — |
| Price / sales | 3.6× | 39.7× |
| Net cash | -$6.39B | $4.54B |
| Dividend yield | — | — |
| Volatility (60d) | 27.9% | 230.5% |
| Short % of float | 3.7% | 9.0% |
| Next earnings | — | Nov 6, 2026 |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).